Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma.,Journal of Clinical Oncology

当前位置： X-MOL 学术 › J. Clin. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma.
Journal of Clinical Oncology ( IF 42.1 ) Pub Date : 2024-05-29 , DOI: 10.1200/jco.2024.42.16_suppl.2005
John Frederick de Groot ₁ , Timothy Francis Cloughesy ₂ , Donald A. Berry ₃ , Meredith Becker Buxton ₄ , Howard Colman ₅ , Benjamin M. Ellingson ₆ , Gary B. Gordon ₄ , Andrew B. Lassman ₇ , Michael Lim ₈ , Ingo K. Mellinghoff ₉ , Erik P. Sulman ₁₀ , Michael Weller ₁₁ , Patrick Y. Wen ₁₂ , Emma Maria Viktoria Hyddmark ₄ , Tom Mikkelsen ₁₃ , Scott Peter Owen ₁₄ , Warren P. Mason ₁₅ , Jan Drappatz ₁₆ , Nicholas Alfred Blondin ₁₇ , James R. Perry ₁₈ ,

Affiliation

University of California, San Francisco, San Francisco, CA
Department of Neurology, University of California, Los Angeles, California, Los Angeles, CA
Berry Consultants, LLC, Austin, TX
Global Coalition for Adaptive Research, Larkspur, CA
Hunstman Cancer Institute at the University of Utah, Salt Lake City, UT
University of California, Los Angeles, Los Angeles, CA
Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
Stanford University, Palo Alto, CA
Memorial Sloan Kettering Cancer Center, New York, NY
Department of Radiation Oncology, NYU Grossman School of Medicine, New York, NY
Department of Neurology, University Hospital Zurich, and Brain Tumor Centre, University Hospital and University of Zurich, University Hospital Zurich, Zurich, Switzerland
Division of Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Henry Ford Health System, Detroit, MI
McGill University Health Centre, Montreal, QC, Canada
Princess Margaret Cancer Centre, Toronto, ON, Canada
University of Pittsburgh Cancer Institute, Pittsburgh, PA
Yale School of Medicine, New Haven, CT
Sunnybrook Health Sciences Centre, Toronto, ON, Canada